The purpose of this symposium is to explore the present state of Heart Failure (HF) training and immediate needs of the medical community from HF specialists. Virtual round table discussions involving a diverse panel of clinicians, including HF program directors and others who care for patients with HF and complex cardiomyopathies, will be undertaken to identify 3-5 high level HF training aims. Workforces will be created around these aims with the overall goal of enhancing the educational toolset provided to community and academic medical centers and practices who care for patients with HF and complex cardiomyopathies.

This virtual symposium will be offered free of charge. While many participants will be invited guests, general registration is available and you will receive a confirmation link once your application is reviewed and your spot is confirmed. We have limited participation to 200 participations.

The Problem: The field of Advanced Heart Failure and Transplant Cardiology (AHFTC) is failing to attract trainees.

Per 2022 AHA Statistics the "prevalence of HF in the US is projected to increase by 46% from 2012 to 2030, affecting >8 million adults." Despite increasing disease burden in the population, as well as emerging diagnostic and therapeutic complexities involving multiple stakeholders including Heart Failure disease specialists, AHFTC as a career has been met with continually waning interest among cardiology trainees. In 2022 only 69 individuals matched into AHFTC fellowships in the United States, a decreasing trend from prior years (n=75 in 2021, and n=80 in 2020). As compared to cardiovascular disease (1.5 applicants per position) and electrophysiology (1.0 applicants per position) fellowships, interest in AHFTC fellowship training is low (0.6 applicants per position).